Keywords: smaller, firms, losses, grow, due, costs, pharmaceutical

Smaller US Firms' Losses Grow Due To R&D Costs

Article | 31 July 1997

Print This

The smaller US pharmaceutical companies as well as biotechnology firmshave been investing heavily in R&D during the first six ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in